Torigen Pharmaceuticals Secures $3.1 Million in Series A Financing

February 18, 2019

Financial Content – Torigen Pharmaceuticals, a company developing personalized cancer immunotherapies for the veterinary market, announced today the completion of a $3.1 million Series A financing round led by Connecticut Innovations, which included the conversion of outstanding convertible debt and interest.

Celebrating UConn Inventors

UConn Today – “I have not failed. I’ve just found 10,000 ways that won’t work.” “Our greatest weakness lies in giving up. The most certain way to succeed is always to try just one more time.” “Many of life’s failures are people who did not realize how close they were to success when they gave up.”

EBV Alum: ‘To Do What You Love is Priceless’

EBV alumnus Jason Otrin (Nathan Oldham/UConn School of Business)
EBV alumnus Jason Otrin (Nathan Oldham/UConn School of Business)

Imagine a young child wandering alone in the woods on a frigid afternoon, with each passing minute decreasing the likelihood of a successful rescue.

UConn alumnus Jason Otrin would like to encourage emergency responders in Connecticut, and across the nation, to adopt the use of drones for such public-safety emergencies. Continue Reading

What Will Blockchain Do For Us?

February 5, 2019

 

To say Blockchain is a complex concept is an understatement. But to say it’s crucial for savvy business leaders to wrap their heads around it is too.

That’s why the UConn School of Business’ Connecticut Information Technology Institute (CITI) is grabbing the bull by the horns, bringing insights on the emerging and highly adaptable technology to those who need it through workshops, a DappDevs Blockchain chapter, the first-ever Blockchain symposium, and creating new classes this semester. Continue Reading